162 related articles for article (PubMed ID: 25920510)
1. The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients.
Painter D; Smith A; de Tute R; Crouch S; Roman E; Jack A
Br J Haematol; 2015 Jul; 170(2):175-8. PubMed ID: 25920510
[TBL] [Abstract][Full Text] [Related]
2. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
[TBL] [Abstract][Full Text] [Related]
4. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.
Sovani V; Harvey C; Haynes AP; McMillan AK; Clark DM; O'Connor SR
J Clin Pathol; 2014 May; 67(5):389-95. PubMed ID: 24327662
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
[TBL] [Abstract][Full Text] [Related]
7. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
[TBL] [Abstract][Full Text] [Related]
9. [Cytogenetic and clinical study on 126 cases of B cell non-Hodgkin's lymphoma with bone marrow involvement].
An G; Zhang JW; Shi LH; Yi SH; Zhao YZ; Qi JY; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):34-7. PubMed ID: 21429399
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
[TBL] [Abstract][Full Text] [Related]
11. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy.
Adams HJ; Kwee TC; Lokhorst HM; Westerweel PE; Fijnheer R; Kersten MJ; Verkooijen HM; Stoker J; Nievelstein RA
J Magn Reson Imaging; 2014 Jun; 39(6):1394-400. PubMed ID: 24310955
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
[TBL] [Abstract][Full Text] [Related]
13. [The value of combined use of bone marrow smear and section in lymphoma for diagnosis and staging].
Cui P; Lou F; Fu Y
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):473-5. PubMed ID: 11798685
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
Benner MF; Willemze R
Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
[TBL] [Abstract][Full Text] [Related]
16. Value of bone marrow examination in Hodgkin lymphoma: report of three cases with review of literature.
Kini JR; Suresh PK; Sinha R; Sahu KK; Kumar S; Prasad K
J Cancer Res Ther; 2012; 8(3):457-9. PubMed ID: 23174737
[TBL] [Abstract][Full Text] [Related]
17. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
[TBL] [Abstract][Full Text] [Related]
19. Precision of histological bone marrow staging in follicular lymphoma and diffuse large B-cell lymphoma.
Chen T; McDonald A; Shadbolt B; Talaulikar D
Clin Invest Med; 2012 Dec; 35(6):E358-64. PubMed ID: 23217561
[TBL] [Abstract][Full Text] [Related]
20. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
Senff NJ; Kluin-Nelemans HC; Willemze R
Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
